Intergalactic Therapeutics
Weiping Zou, M.D., Ph.D., is a Professor of Pathology, Immunology, Biology, and Surgery at the University of Michigan and Director of the Michigan Center of Excellence for Cancer Immunology and Immunotherapy. He was the AACR Cancer Immunology (CIMM) Chairperson 2019-2020 and has served as the AAl Cancer Immunology Abstract Programming Chair for four years. He has published more than 200 articles and book chapters, including 36 articles in Nature, Science, and Cell journal series. His laboratory is one of the most-cited research teams in the field of immunology. His early concept of combinatorial immunotherapeutic strategies has laid the foundation for current cancer immunotherapy and has provided rationales for novel combinations.
This person is not in the org chart
This person is not in any offices
Intergalactic Therapeutics
At Intergalactic Therapeutics, they are building the future of non-viral gene therapy and expanding the therapeutic universe for patients.